Study · verified by the research team
Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi)
Nortier JL, Martinez MC, Schmeiser HH, et al. · 2000 · New England Journal of Medicine 342(23): 1686–1692
https://doi.org/10.1056/NEJM200006083422301
Showed high prevalence of urothelial cancer among Belgian patients with Chinese-herb nephropathy, with aristolochic-acid DNA adducts in all tissues.
Study details
| Design | Clinical-pathological study of prophylactically removed kidneys and ureters |
|---|---|
| Population | 39 patients with end-stage Chinese-herb nephropathy |
| Outcome | Urothelial carcinoma; aristolochic acid–DNA adducts |
| Finding | 18 of 39 (46%) had urothelial carcinoma; all samples contained aristolochic-acid DNA adducts; cumulative doses >200 g associated with higher risk |
| Limitations | Single cohort; no unexposed comparison group |
| Certainty | high |